Daewon Pharmaceutical Co., Ltd. 003220.KS Stock
Daewon Pharmaceutical Co., Ltd. Price Chart
Daewon Pharmaceutical Co., Ltd. 003220.KS Financial and Trading Overview
| Daewon Pharmaceutical Co., Ltd. stock price | 14600 KRW |
| Previous Close | 13890 KRW |
| Open | 13900 KRW |
| Bid | 13970 KRW x 0 |
| Ask | 13980 KRW x 0 |
| Day's Range | 13900 - 14030 KRW |
| 52 Week Range | 13860 - 21800 KRW |
| Volume | 47.09K KRW |
| Avg. Volume | 78.49K KRW |
| Market Cap | 293.17B KRW |
| Beta (5Y Monthly) | 0.589726 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 350 (2.47%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | 21333 KRW |
003220.KS Valuation Measures
| Enterprise Value | 355.95B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.6033285 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.733 |
| Enterprise Value/EBITDA | 6.217 |
Trading Information
Daewon Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.589726 |
| 52-Week Change | -12.088% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21800 KRW |
| 52 Week Low | 13860 KRW |
| 50-Day Moving Average | 14681.8 KRW |
| 200-Day Moving Average | 16080.05 KRW |
003220.KS Share Statistics
| Avg. Volume (3 month) | 78.49K KRW |
| Avg. Daily Volume (10-Days) | 64.81K KRW |
| Shares Outstanding | 20.97M |
| Float | 12.51M |
| Short Ratio | N/A |
| % Held by Insiders | 38.93% |
| % Held by Institutions | 13.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 139.00% |
| Payout Ratio | 0.24219999 |
| Last Split Factor | 1.03:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 6.39% |
| Operating Margin (ttm) | 7.83% |
| Gross Margin | 49.18% |
| EBITDA Margin | 11.78% |
Management Effectiveness
| Return on Assets (ttm) | 5.25% |
| Return on Equity (ttm) | 12.64% |
Income Statement
| Revenue (ttm) | 485.92B KRW |
| Revenue Per Share (ttm) | 23032.84 KRW |
| Quarterly Revenue Growth (yoy) | 6.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | 57.25B KRW |
| Net Income Avi to Common (ttm) | 31.07B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | -8.30% |
Balance Sheet
| Total Cash (mrq) | 47.09B KRW |
| Total Cash Per Share (mrq) | 2245.39 KRW |
| Total Debt (mrq) | 114.04B KRW |
| Total Debt/Equity (mrq) | 45.47 KRW |
| Current Ratio (mrq) | 1.593 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 34.09B KRW |
| Levered Free Cash Flow (ttm) | 10.17B KRW |
Profile of Daewon Pharmaceutical Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 386 Cheonhodae-ro |
| ZIP | N/A |
| Phone | 82 2 2204 7000 |
| Website | https://www.daewonpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1082 |
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.
Q&A For Daewon Pharmaceutical Co., Ltd. Stock
What is a current 003220.KS stock price?
Daewon Pharmaceutical Co., Ltd. 003220.KS stock price today per share is 14600 KRW.
How to purchase Daewon Pharmaceutical Co., Ltd. stock?
You can buy 003220.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Daewon Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Daewon Pharmaceutical Co., Ltd. is 003220.KS.
Which industry does the Daewon Pharmaceutical Co., Ltd. company belong to?
The Daewon Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Daewon Pharmaceutical Co., Ltd. have in circulation?
The max supply of Daewon Pharmaceutical Co., Ltd. shares is 21.2M.
What is Daewon Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Daewon Pharmaceutical Co., Ltd. PE Ratio is now.
What was Daewon Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Daewon Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Daewon Pharmaceutical Co., Ltd. company belong to?
The Daewon Pharmaceutical Co., Ltd. sector is Healthcare.